H. Lundbeck Future Growth
Future criteria checks 4/6
H. Lundbeck is forecast to grow earnings and revenue by 26.7% and 6.3% per annum respectively.
Key information
26.7%
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 13.6% |
Revenue growth rate | 6.3% |
Future return on equity | 15.8% |
Analyst coverage | Good |
Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 20,536 | 3,449 | 4,157 | 5,044 | 13 |
12/31/2023 | 18,941 | 2,543 | 3,370 | 4,202 | 14 |
12/31/2022 | 17,350 | 1,524 | 1,334 | 2,601 | 14 |
3/31/2022 | 16,398 | 1,109 | 1,344 | 1,959 | N/A |
12/31/2021 | 16,299 | 1,318 | 1,660 | 2,272 | N/A |
9/30/2021 | 16,521 | 1,873 | 2,405 | 2,949 | N/A |
6/30/2021 | 16,971 | 1,965 | 2,379 | 2,912 | N/A |
3/31/2021 | 17,381 | 2,110 | 3,263 | 3,757 | N/A |
12/31/2020 | 17,672 | 1,581 | 3,359 | 3,837 | N/A |
9/30/2020 | 17,818 | 904 | 2,713 | 3,171 | N/A |
6/30/2020 | 17,490 | 1,242 | 2,910 | 3,354 | N/A |
3/31/2020 | 17,366 | 1,507 | 1,502 | 1,960 | N/A |
12/31/2019 | 17,036 | 2,313 | 2,165 | 2,609 | N/A |
9/30/2019 | 16,811 | 3,091 | 3,210 | 3,621 | N/A |
6/30/2019 | 17,309 | 3,395 | 2,736 | 3,462 | N/A |
3/31/2019 | 17,766 | 3,606 | 4,100 | 4,815 | N/A |
12/31/2018 | 18,117 | 3,907 | 5,277 | 5,981 | N/A |
9/30/2018 | 18,313 | 3,806 | 5,057 | 5,922 | N/A |
6/30/2018 | 18,028 | 3,627 | 5,368 | 6,197 | N/A |
3/31/2018 | 17,608 | 3,236 | 4,629 | 5,397 | N/A |
12/31/2017 | 17,234 | 2,624 | 3,320 | 4,045 | N/A |
9/30/2017 | 17,007 | 2,544 | 3,185 | 3,731 | N/A |
6/30/2017 | 16,607 | 1,988 | 3,289 | 3,551 | N/A |
3/31/2017 | 16,075 | 1,612 | 3,115 | 3,420 | N/A |
12/31/2016 | 15,634 | 1,211 | 2,784 | 3,126 | N/A |
9/30/2016 | 15,202 | 290 | 2,536 | 4,158 | N/A |
6/30/2016 | 14,923 | -1,289 | -152 | 2,755 | N/A |
3/31/2016 | 14,801 | -5,427 | -1,915 | 936 | N/A |
12/31/2015 | 14,594 | -5,694 | N/A | 197 | N/A |
9/30/2015 | 14,108 | -5,879 | N/A | -1,330 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LUN's forecast earnings growth (26.7% per year) is above the savings rate (0.2%).
Earnings vs Market: LUN's earnings (26.7% per year) are forecast to grow faster than the Austrian market (7.2% per year).
High Growth Earnings: LUN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LUN's revenue (6.3% per year) is forecast to grow faster than the Austrian market (-3.6% per year).
High Growth Revenue: LUN's revenue (6.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LUN's Return on Equity is forecast to be low in 3 years time (15.8%).